Abstract: An apparatus of a setting welding device for an auxiliary joining part with a head and a shaft, includes a linear drive fastenable at the setting device and including an element nest at a movable end, in which an auxiliary joining part is releasably receivable from a transfer unit. The element nest is movable by the linear drive in a first direction. The element nest is supported in a floating manner, and is positionable via a mechanical stop alignment in abutment with an electrode punch in the joining direction below the electrode punch. And/or the element nest is connected with the linear drive via a mechanical direction-changing coupling component so that the element nest is movable by the linear drive in a second direction so that the auxiliary joining part is positionable at the joining location, wherein the second direction is not parallel to the first direction.

Abstract: An apparatus of a setting welding device for an auxiliary joining part with a head and a shaft, includes a linear drive fastenable at the setting device and including an element nest at a movable end, in which an auxiliary joining part is releasably receivable from a transfer unit. The element nest is movable by the linear drive in a first direction. The element nest is supported in a floating manner, and is positionable via a mechanical stop alignment in abutment with an electrode punch in the joining direction below the electrode punch. And/or the element nest is connected with the linear drive via a mechanical direction-changing coupling component so that the element nest is movable by the linear drive in a second direction so that the auxiliary joining part is positionable at the joining location, wherein the second direction is not parallel to the first direction.

Abstract: Systems, devices, and methods for performing minimally invasive spinal procedures are described herein. The systems, devices, and methods may be used to percutaneously access the spinal canal and perform a spinal procedure in multiple locations along the canal, e.g., bilaterally and/or at multiple levels from a single access point. The systems and devices may integrate various instruments for performing the procedures, thus improving their ease of use, reducing procedural complexity, and minimizing procedure time.

Abstract: A setting head for a joining device, such as a press or a setting device, which setting head comprises the following features: a punch which is movable in a longitudinal direction such that a joining element can be joined into a component by means of a punch face arranged at a working end of the punch; a hollow cylindrical receiving sleeve which has a through-passage and which, with the punch in the through-passage, is guided adjacent to the working end of the punch concentrically and axially movably thereon; and two mutually opposite holding arms arranged on the receiving sleeve outside the through-passage each provide at least one laterally inwardly projecting holding end, with the result that the at least two holding ends allow the joining element to be releasably positionable adjacent to a punch-remote outlet opening of the through-passage and by the axially movable working end of the punch.

Abstract: A rechargeable medical implant system for sacral stimulation therapy. The device includes a rechargeable power source that wireless charges via an external portable charger device having an audio transducer operably coupled with associated circuitry configured to provide audio feedback to assist the patient in recharging the neurostimulator device. The audio feedback includes two alerts where a first audio alert to indicate that the external charger device is aligned and that coupling between the wireless transmitting unit and the wireless receiving unit has occurred a second audio alert that indicates that the implantable neurostimulator device is fully charged, wherein the second audio alert is different from the first audio alert.

Abstract: Methods and systems for obtaining and analyzing electromyography responses of electrodes of an implanted neurostimulation lead for use neurostimulation programming are provided herein. System setups for neural localization and/or programming include a clinician programmer coupleable with a temporary or permanent lead implantable in a patient and at least one pair of EMG sensing electrodes minimally invasively positioned on a skin surface or within the patient. The clinician programmer is configured to determine a plurality of recommended electrode configurations based on thresholds and EMG responses of the plurality of electrodes and rank the electrode configuration according to pre-determined criteria.

Abstract: Methods for transcutaneous charging of an implanted device may include removably coupling a charging device with a carrier having adhesive tabs, the tabs being movable between a first position configured to be spaced away from a skin surface and a second position configured to be urged against the skin surface; engaging a bottom surface of the charging device at least partially against the skin surface with the tabs in the first position; positioning the charging device until it is at least partially positioned over or proximate the implanted medical device; and moving the tabs to the second position so that respective adhesive surfaces of the tabs contact and adhere to the skin of the patient sufficiently to support the charging device coupled with the carrier for a duration of time sufficient to charge the implanted device.

Abstract: Systems and methods for providing a trial neurostimulation to a patient for assesssing suitability of a permanently implanted neurostimulation are provided herein. In one aspect, a trial neurostimulation system includes an EPG patch adhered to a skin surface of a patient and connected to a lead extending through a percutaneous incision to a target tissue location. The EPG may be a modified version of the IPG used in the permanent system, the EPG may be smaller and/or lighter than the corresponding IPG device. The EPG and a lead extension may be sealed to allow improved patient mobility and reduced risk of infection. The EPG may be compatible with wireless systems used to control and monitor the IPG such that operation and control of the EPG is substantially the same in each system to allow seemless conversion to the permanently implanted system.

Abstract: The present invention provides improved methods for positioning of an implantable lead in a patient with an integrated EMG and stimulation clinician programmer. The integrated clinician programmer is coupled to the implantable lead, wherein the implantable lead comprises at least four electrodes, and to at least one EMG sensing electrode minimally invasively positioned on a skin surface or within the patient. The method comprises delivering a test stimulation at a stimulation amplitude level from the integrated clinician programmer to a nerve tissue of the patient with a principal electrode of the implantable lead. Test stimulations are delivered at a same stimulation amplitude level for a same period of time sequentially to each of the four electrodes of the implantable lead.

Abstract: The present invention provides improved methods for positioning of an implantable lead in a patient with an integrated EMG and stimulation clinician programmer. The integrated clinician programmer is coupled to the implantable lead, wherein the implantable lead comprises at least four electrodes, and to at least one EMG sensing electrode minimally invasively positioned on a skin surface or within the patient. The method comprises delivering a test stimulation at a stimulation amplitude level from the integrated clinician programmer to a nerve tissue of the patient with a principal electrode of the implantable lead. Test stimulations are delivered at a same stimulation amplitude level for a same period of time sequentially to each of the four electrodes of the implantable lead.

Abstract: Methods for transcutaneous charging of an implanted device may include removably coupling a charging device with a carrier having adhesive tabs, the tabs being movable between a first position configured to be spaced away from a skin surface and a second position configured to be urged against the skin surface; engaging a bottom surface of the charging device at least partially against the skin surface with the tabs in the first position; positioning the charging device until it is at least partially positioned over or proximate the implanted medical device; and moving the tabs to the second position so that respective adhesive surfaces of the tabs contact and adhere to the skin of the patient sufficiently to support the charging device coupled with the carrier for a duration of time sufficient to charge the implanted device.

Abstract: Systems and methods for providing a trial neurostimulation to a patient for assessing suitability of a permanently implanted neurostimulation are provided herein. In one aspect, a trial neurostimulation system includes an EPG affixation device that secures the EPG to the patient when connected to a lead extending through a percutaneous incision to a target tissue location, while allowing for ready removal of the EPG for charging or bathing. In another aspect, the system includes an EPG provided with a multi-purpose connector rectacle through which the EPG can deliver neurostimulation therapy to an implanted lead or the EPG can be charged. In yet another aspect, the EPG can include a multi-purpose connector receptacle that is alternatingly connectable with a plurality of differing connector to facilitate differing types of therapies with one or more neurostimulation devices, ground patches or various other devices, such as charging or testing devices.

Abstract: Systems and methods for providing a trial neurostimulation to a patient for assesssing suitability of a permanently implanted neurostimulation are provided herein. In one aspect, a trial neurostimulation system includes an EPG patch adhered to a skin surface of a patient and connected to a lead extending through a percutaneous incision to a target tissue location. The EPG may be a modified version of the IPG used in the permanent system, the EPG may be smaller and/or lighter than the corresponding IPG device. The EPG and a lead extension may be sealed to allow improved patient mobility and reduced risk of infection. The EPG may be compatible with wireless systems used to control and monitor the IPG such that operation and control of the EPG is substantially the same in each system to allow seemless conversion to the permanently implanted system.

Abstract: A setting head for a joining device, such as a press or a setting device, which setting head comprises the following features: a punch which is movable in a longitudinal direction such that a joining element can be joined into a component by means of a punch face arranged at a working end of the punch; a hollow cylindrical receiving sleeve which has a through-passage and which, with the punch in the through-passage, is guided adjacent to the working end of the punch concentrically and axially movably thereon; and two mutually opposite holding arms arranged on the receiving sleeve outside the through-passage each provide at least one laterally inwardly projecting holding end, with the result that the at least two holding ends allow the joining element to be releasably positionable adjacent to a punch-remote outlet opening of the through-passage and by the axially movable working end of the punch.

Abstract: Systems and methods for providing a trial neurostimulation to a patient for assessing suitability of a permanently implanted neurostimulation are provided herein. In one aspect, a trial neurostimulation system includes an EPG affixation device that secures the EPG to the patient when connected to a lead extending through a percutaneous incision to a target tissue location, while allowing for ready removal of the EPG for charging or bathing. In another aspect, the system includes an EPG provided with a multi-purpose connector receptacle through which the the EPG can deliver neurostimulation therapy to an implanted lead or the EPG can be charged. In yet another aspect, the EPG can include a multi-purpose connector receptacle that is alternatingly connectable with a plurality of differing connector to facilitate differing types of therapies with one or more neurostimulation devices, ground patches or various other devices, such as charging or testing devices.

Abstract: A neurostimulation system having an external or an implantable pulse generator programmed to innervate a specific nerve or group of nerves in a patient through an electrode as a mode of treatment, having a patient remote that wirelessly communicates with the pulse generator to increase stimulation, decrease stimulation, and provide indications to a patient regarding the status of the neurostimulation system. The patient remote can allow for adjustment of stimulation power within a clinically effective range and for turning on and turning off the pulse generator. The patient remote and neurostimulation system can also store a stimulation level when the pulse generator is turned off and automatically restore the pulse generator to the stored stimulation level when the pulse generator is turned on.

Abstract: A neurostimulation system having an external or an implantable pulse generator programmed to innervate a specific nerve or group of nerves in a patient through an electrode as a mode of treatment, having a patient remote that wirelessly communicates with the pulse generator to increase stimulation, decrease stimulation, and provide indications to a patient regarding the status of the neurostimulation system. The patient remote can allow for adjustment of stimulation power within a clinically effective range and for turning on and turning off the pulse generator. The patient remote and neurostimulation system can also store a stimulation level when the pulse generator is turned off and automatically restore the pulse generator to the stored stimulation level when the pulse generator is turned on.

Abstract: A clinician programmer may be coupled with an implantable temporary or permanent lead in a patient. Generally, the clinician programmer may comprise a portable housing, a signal/stimulation generator, and a graphical user interface. The housing has an external surface and encloses circuitry at least partially disposed within the housing. The signal/stimulation generator may be disposed within the housing and configured to deliver test stimulation to a nerve tissue of the patient via the implantable lead. The graphical user interface at least partially comprises the external surface of the housing and has a touch screen display for direct user interaction or for use with a keyboard, mouse, or the like.

Abstract: An apparatus of a setting welding device for an auxiliary joining part with a head and a shaft, includes a linear drive fastenable at the setting device and including an element nest at a movable end, in which an auxiliary joining part is releasably receivable from a transfer unit. The element nest is movable by the linear drive in a first direction. The element nest is supported in a floating manner, and is positionable via a mechanical stop alignment in abutment with an electrode punch in the joining direction below the electrode punch. And/or the element nest is connected with the linear drive via a mechanical direction-changing coupling component so that the element nest is movable by the linear drive in a second direction so that the auxiliary joining part is positionable at the joining location, wherein the second direction is not parallel to the first direction.

Abstract: Methods for transcutaneous charging of an implanted device may include removably coupling a charging device with a carrier having adhesive tabs, the tabs being movable between a first position configured to be spaced away from a skin surface and a second position configured to be urged against the skin surface; engaging a bottom surface of the charging device at least partially against the skin surface with the tabs in the first position; positioning the charging device until it is at least partially positioned over or proximate the implanted medical device; and moving the tabs to the second position so that respective adhesive surfaces of the tabs contact and adhere to the skin of the patient sufficiently to support the charging device coupled with the carrier for a duration of time sufficient to charge the implanted device.